Certified Global Research Member

Key Questions Answered

Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the key challenges in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major playersâ€™ financial performance.
Evaluate strategies adopted by major players.
Recommendations

Why Choose Market Research Future?

Vigorous research methodologies for specific market.
Knowledge partners across the globe
Large network of partner consultants.
Ever-increasing/ Escalating data base with quarterly monitoring of various markets
Trusted by fortune 500 companies/startups/ universities/organizations
Large database of 5000+ markets reports.
Effective and prompt pre- and post-sales support.

Dercums Disease Companies

Dercum's Disease, also known as Adiposis Dolorosa, is a rare and poorly understood condition characterized by painful fatty deposits under the skin. Companies involved in the field of Dercum's Disease typically focus on research, patient support, and the development of treatments for symptom management.

Dercum’s Disease Key Companies *Disclaimer: List of key companies in no particular orderLatest Dercum's Disease Companies Update

May 2023: Allergan Aesthetics, an AbbVie business (NYSE: ABBV), announced that SKINVIVETM by JUVÉDERM® has received FDA approval in the United States to enhance cheek skin smoothness in individuals over 21. With benefits that last up to six months with the best care, it is the first and only intradermal microdroplet injection of hyaluronic acid (HA) for skin smoothness accessible in the United States. Smooth and injectable HA gel, SKINVIVETM by JUVÉDERM® includes a trace dose of local anesthetic lidocaine. By improving hydration and smoothing the skin, SKINVIVETM by JUVÉDERM® enhances cheek skin quality in contrast to other cosmetic injectables that accentuate and enhance the treatment region. The cream fills a significant need in the skin quality area. It is a smooth, hydrating gel that melts into the skin and is suitable for all Fitzpatrick Skin Types, from lightest to darkest.

Jan 2023: Novaliq GmbH, a biopharmaceutical company focused on first- and best-in-class ocular therapeutics, and Bausch + Lomb Corporation, an established global eye health company committed to helping people see better to live better, today announced that Ophthalmology, a peer-reviewed publication of the American Academy of Ophthalmology, recently published results from the essential Phase 3 trial GOBI, which is one of the two pivotal Phase 3 trials for NOV03 (perfluorohexyloctane). The efficacious treatment of dry eye disorder (DED) related to malfunction of the meibomian gland (MGD) is being studied with NOV03. NOV03 has been assigned a Prescription Drug User Fee Act (PDUFA) by the U.S. Food and Drug Administration (FDA).

List of Dercum's Disease Key companies in the market

Pfizer Inc (US)

Abbvie, Inc (US)

Johnson & Johnson Services, Inc (US)

GlaxoSmithKline plc (UK)

Bausch & Lomb Incorporated (Canada)

Caliway (Taiwan)

Raziel Therapeutics Ltd (Israel)

Nivarta, Inc (US)

BHR Pharmaceuticals Ltd (UK)

Novartis International AG (Switzerland)

Dercums Disease Market Highlights:

Dercums Disease Market Size

Dercums Disease Market Trends

Dercums Disease Market Analysis

Dercums Disease Market Share

Dercums Disease Market Highlights:

Dercums Disease Market Trends

Dercums Disease Market Analysis

Dercums Disease Market Share

Dercums Disease Companies

Leading companies partner with us for data-driven Insights

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
	Single User	$ 4,950
	Multiuser License	$ 5,950
	Enterprise User	$ 7,250
Compare Licenses

Tailored for You

Dedicated Research on any specifics segment or region.
Focused Research on specific players in the market.
Custom Report based only on your requirements.
Flexibility to add or subtract any chapter in the study.
Historic data from 2014 and forecasts outlook till 2040.
Flexibility of providing data/insights in formats (PDF, PPT, Excel).
Provide cross segmentation in applicable scenario/markets.